Cerevast Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • 2ndary - Private

Cerevast General Information

Description

Developer of medical products and devices designed to be used for the treatment of neurologic disorders. The company's devices use transdermal electrical neurostimulation (TENS) which involves the use of low voltage electric current to modulate nerves for therapeutic purposes, enabling patients to get effective treatment from neurologic disorders and achieve stroke recovery, stress reduction, and sleep.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 12100 Northeast 195th Street
  • Suite 150
  • Bothell, WA 98011
  • United States
+1 (425)
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 12100 Northeast 195th Street
  • Suite 150
  • Bothell, WA 98011
  • United States
+1 (425)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cerevast Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private 01-Jul-2021 Completed Generating Revenue
6. Secondary Transaction - Private 01-Sep-2015 Completed Generating Revenue
5. Later Stage VC (Series C) 03-Mar-2015 Completed Generating Revenue
4. Later Stage VC (Series C) 22-Apr-2013 Completed Generating Revenue
3. Later Stage VC (Series C) 12-Nov-2011 Completed Generating Revenue
2. Early Stage VC (Series B) 06-Jan-2010 $2.19M $3.09M Completed Generating Revenue
1. Early Stage VC (Series A) 18-Sep-2009 $900K $900K Completed Startup
To view Cerevast’s complete valuation and funding history, request access »

Cerevast Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 1,799,700 $0.000100 $0.5 $0.5 1x $0.5 16.26%
To view Cerevast’s complete cap table history, request access »

Cerevast Patents

Cerevast Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220032089-A1 Ultrasound visualization, and associated systems and methods Inactive 31-Jul-2020
WO-2017106411-A1 Electrodes having surface exclusions Inactive 15-Dec-2015
WO-2016196635-A2 Apparatuses and methods for neuromodulation Inactive 01-Jun-2015
WO-2016196635-A3 Apparatuses and methods for neuromodulation Inactive 01-Jun-2015
EP-3302682-A1 Methods and apparatuses for transdermal electrical stimulation Inactive 29-May-2015 A61N1/0492
To view Cerevast’s complete patent history, request access »

Cerevast Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cerevast FAQs

  • When was Cerevast founded?

    Cerevast was founded in 2009.

  • Where is Cerevast headquartered?

    Cerevast is headquartered in Bothell, WA.

  • What is the size of Cerevast?

    Cerevast has 5 total employees.

  • What industry is Cerevast in?

    Cerevast’s primary industry is Diagnostic Equipment.

  • Is Cerevast a private or public company?

    Cerevast is a Private company.

  • What is Cerevast’s current revenue?

    The current revenue for Cerevast is .

  • How much funding has Cerevast raised over time?

    Cerevast has raised $32.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process